Literature DB >> 15005694

Development of pemphigus herpetiformis in a patient with psoriasis receiving UV-light treatment.

Carla Sanchez-Palacios1, Lawrence S Chan.   

Abstract

BACKGROUND: Pemphigus is an autoimmune blistering disease of the skin and mucous membranes. Pemphigus herpetiformis, a rare variant of pemphigus, is characterized by erythematous, vesicular, bullous, or papular lesions in a herpetiform pattern, often associated with pruritus. Clinical cases documenting the development of pemphigus in patients with a history of psoriasis have been reported in the literature.
METHODS: We used immunological methods to study a case in which pemphigus herpetiformis occurred in a woman with a history of psoriasis, shortly after a course of ultraviolet B (UVB) therapy.
RESULTS: Histopathology revealed a subcorneal blister with prominent neutrophilic infiltration. Immunopathology detected in situ bound and circulating immunoglobulin G (IgG) autoantibodies to epithelial cell surfaces and circulating IgG autoantibodies against desmoglein 1. The patient was also found to have Hashimoto's thyroiditis.
CONCLUSIONS: This case illuminates a possible role of UV therapy in the induction of pemphigus herpetiformis through an epitope-spreading mechanism. The patient's autoimmune thyroiditis may also contribute to the predisposition for pemphigus development. The histopathological findings in pemphigus patients with a history of psoriasis may resemble Munro's microabscesses of psoriasis and should therefore alert pathologists and clinicians in considering additional diagnostic methods such as direct and indirect immunofluorescence.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15005694     DOI: 10.1111/j.0303-6987.2004.0188.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  9 in total

1.  The coexistence of pemphigus and psoriasis: a systematic review and meta-analysis.

Authors:  Khalaf Kridin; Mouhammad Kridin; Guy Shalom; Arnon D Cohen
Journal:  Immunol Res       Date:  2019-02       Impact factor: 2.829

2.  Pemphigus Foliaceus Associated with Psoriasis during the Course of Narrow-Band UVB Therapy: A Simple Coincidence?

Authors:  Hyuck Hoon Kwon; In Ho Kwon; Jin Ho Chung; Jai Il Youn
Journal:  Ann Dermatol       Date:  2011-12-27       Impact factor: 1.444

Review 3.  Pemphigus group: overview, epidemiology, mortality, and comorbidities.

Authors:  Khalaf Kridin
Journal:  Immunol Res       Date:  2018-04       Impact factor: 2.829

Review 4.  Interaction of Psoriasis and Bullous Diseases.

Authors:  Teruki Dainichi; Kenji Kabashima
Journal:  Front Med (Lausanne)       Date:  2018-08-08

Review 5.  Skin Barrier and Autoimmunity-Mechanisms and Novel Therapeutic Approaches for Autoimmune Blistering Diseases of the Skin.

Authors:  Natalie E Stevens; Allison J Cowin; Zlatko Kopecki
Journal:  Front Immunol       Date:  2019-05-14       Impact factor: 7.561

Review 6.  A Review of Acquired Autoimmune Blistering Diseases in Inherited Epidermolysis Bullosa: Implications for the Future of Gene Therapy.

Authors:  Payal M Patel; Virginia A Jones; Christy T Behnam; Giovanni Di Zenzo; Kyle T Amber
Journal:  Antibodies (Basel)       Date:  2021-05-17

Review 7.  Molecular diagnosis in autoimmune skin blistering conditions.

Authors:  J V Otten; T Hashimoto; M Hertl; A S Payne; C Sitaru
Journal:  Curr Mol Med       Date:  2014-01       Impact factor: 2.222

Review 8.  Non-classical forms of pemphigus: pemphigus herpetiformis, IgA pemphigus, paraneoplastic pemphigus and IgG/IgA pemphigus.

Authors:  Adriana Maria Porro; Livia de Vasconcelos Nasser Caetano; Laura de Sena Nogueira Maehara; Milvia Maria dos Santos Enokihara
Journal:  An Bras Dermatol       Date:  2014 Jan-Feb       Impact factor: 1.896

9.  The desmosomal protein desmoglein 1 aids recovery of epidermal differentiation after acute UV light exposure.

Authors:  Jodi L Johnson; Jennifer L Koetsier; Anna Sirico; Ada T Agidi; Dario Antonini; Caterina Missero; Kathleen J Green
Journal:  J Invest Dermatol       Date:  2014-03-04       Impact factor: 8.551

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.